182 related articles for article (PubMed ID: 36446332)
1. The History of the Insulin-Like Growth Factor System.
Miller BS; Rogol AD; Rosenfeld RG
Horm Res Paediatr; 2022; 95(6):619-630. PubMed ID: 36446332
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment options.
Kemp SF
BioDrugs; 2009; 23(3):155-63. PubMed ID: 19627167
[TBL] [Abstract][Full Text] [Related]
3. A half-century of studies of growth hormone insensitivity/Laron syndrome: A historical perspective.
Rosenbloom AL
Growth Horm IGF Res; 2016 Jun; 28():46-50. PubMed ID: 26276451
[TBL] [Abstract][Full Text] [Related]
4. Clinical use of somatomedin-1: yes or no?
Laron Z
Paediatr Drugs; 1999; 1(3):155-9. PubMed ID: 10937448
[TBL] [Abstract][Full Text] [Related]
5. Genetic defects of the growth-hormone-IGF axis associated with growth hormone insensitivity.
Woods K
Endocr Dev; 2007; 11():6-15. PubMed ID: 17986822
[TBL] [Abstract][Full Text] [Related]
6. The anabolic effects of GH/IGF system on bone.
Kasukawa Y; Miyakoshi N; Mohan S
Curr Pharm Des; 2004; 10(21):2577-92. PubMed ID: 15320746
[TBL] [Abstract][Full Text] [Related]
7. A personal view on the early history of the insulin-like growth factors.
Van den Brande JL
Horm Res; 1999; 51 Suppl 3():149-75. PubMed ID: 10592460
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone insensitivity syndromes: a preliminary report on changes in insulin-like growth factors and their binding proteins during treatment with recombinant insulin-like growth factor I. Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
Blum WF; Hall K; Ranke MB; Wilton P
Acta Paediatr Suppl; 1993 Sep; 82 Suppl 391():15-9. PubMed ID: 7693071
[TBL] [Abstract][Full Text] [Related]
9. Therapy with recombinant human IGF-1 for children with primary insulin-like growth factor-I deficiency.
Backeljauw P
Growth Horm IGF Res; 2020 Apr; 51():22-26. PubMed ID: 31982729
[TBL] [Abstract][Full Text] [Related]
10. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
[TBL] [Abstract][Full Text] [Related]
11. Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.
Camacho-Hübner C; Woods KA; Miraki-Moud F; Hindmarsh PC; Clark AJ; Hansson Y; Johnston A; Baxter RC; Savage MO
J Clin Endocrinol Metab; 1999 May; 84(5):1611-6. PubMed ID: 10323388
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I treatment in primary growth hormone insensitivity: effect of recombinant human IGF-I (rhIGF-I) and rhIGF-I/rhIGF-binding protein-3 complex.
Tonella P; Flück CE; Mullis PE
Horm Res Paediatr; 2010; 73(2):140-7. PubMed ID: 20190552
[TBL] [Abstract][Full Text] [Related]
13. [Insulin-like growth factors. Future treatment in catabolism?].
Hall K; Bang P; Brismar K
Lakartidningen; 1995 Jun; 92(26-27):2666-71. PubMed ID: 7637446
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-I treatment of children with Laron syndrome (primary growth hormone insensitivity).
Laron Z
Pediatr Endocrinol Rev; 2008 Mar; 5(3):766-71. PubMed ID: 18367997
[TBL] [Abstract][Full Text] [Related]
15. IGFs and IGFBPs in GH insensitivity.
Savage MO; Blair JC; Jorge AJ; Street ME; Ranke MB; Camacho-Hübner C
Endocr Dev; 2005; 9():100-106. PubMed ID: 15879692
[TBL] [Abstract][Full Text] [Related]
16. Genetic disorders of GH action pathway.
Domené HM; Fierro-Carrión G
Growth Horm IGF Res; 2018 Feb; 38():19-23. PubMed ID: 29249625
[TBL] [Abstract][Full Text] [Related]
17. Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.
Drugs R D; 2005; 6(2):120-7. PubMed ID: 15777106
[TBL] [Abstract][Full Text] [Related]
18. Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance.
Hardouin S; Gourmelen M; Noguiez P; Seurin D; Roghani M; Le Bouc Y; Povoa G; Merimee TJ; Hossenlopp P; Binoux M
J Clin Endocrinol Metab; 1989 Dec; 69(6):1291-301. PubMed ID: 2555386
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor -I deficiency.
Camacho-Hübner C; Savage M
Horm Res; 2001; 55 Suppl 1():17-20. PubMed ID: 11408756
[TBL] [Abstract][Full Text] [Related]
20. Long-term auxological and pubertal outcome of patients with hereditary insulin-like growth factor-I deficiency (Laron and growth hormone-gene deletion syndrome) treated with recombinant human insulin-like growth factor-I.
Messina MF; Arrigo T; Valenzise M; Ghizzoni L; Caruso-Nicoletti M; Zucchini S; Chiabotto P; Crisafulli G; Zirilli G; De Luca F
J Endocrinol Invest; 2011 Apr; 34(4):292-5. PubMed ID: 20543555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
